No increase in blood-brain barrier permeability after intraperitoneal injection of endotoxin in the rat

Journal of Neuroimmunology

Volumn 85, Issue 2, 1998, Pages 131-136

  Bickel, Ulrich ^a   Grave, Birgit ^a   Kang, Young Sook ^b   Del Rey, Adriana ^a   Voigt, Karlheinz ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b Sookmyung Women's University   (South Korea)

Author keywords

Albumin; Blood brain barrier; Lipopolysaccharide; Rat; Sucrose

Indexed keywords

ENDOTOXIN; LIPOPOLYSACCHARIDE; SERUM ALBUMIN; SUCROSE;

ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; CELL MEMBRANE PERMEABILITY; DISEASE MODEL; GRAM NEGATIVE INFECTION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BLOOD-BRAIN BARRIER; INJECTIONS, INTRAPERITONEAL; LIPOPOLYSACCHARIDES; MALE; PERMEABILITY; RATS; RATS, SPRAGUE-DAWLEY; SUCROSE;

EID: 0032524174     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(98)00004-6     Document Type: Article

References (28)

1. Banks W.A., Kastin A.J. The interleukins-1α, -1β, and -2 do not acutely disrupt the murine blood-brain barrier. Int. J. Immunopharmacol. 14:1992;629-636.
2. Banks W.A., Kastin A.J., Broadwell R.D. Passage of cytokines across the blood-brain barrier. Neuroimmunomodulation. 2:1995;241-248.
3. Besedovsky H.O., del Rey A. Immune-neuro-endocrine interactions: facts and hypotheses. Endocr. Rev. 17:1996;64-102.
4. Bickel U., Schumacher O.P., Kang Y.S., Voigt K. Poor permeability of morphine 3-glucuronide and morphine 6-glucuronide through the blood-brain barrier in the rat. J. Pharmacol. Exp. Ther. 278:1996;107-113.
5. Blatteis C.M., Sehic E. Fever: How may circulating pyrogens signal the brain? News Physiol. Sci. 12:1997;1-9.
6. Boje K.M.K. Cerebrovascular permeability changes during experimental meningitis in the rat. J. Pharmacol. Exp. Ther. 274:1995;1199-1203.
7. Derijk R., van Rooijen N., Tilders F.J.H., Besedovsky H.O., del Rey A., Berkenbosch F. Selective depletion of macrophages prevents pituitary-adrenal activation in response to subpyrogenic, but not to pyrogenic, doses of bacterial endotoxin in rats. Endocrinology. 128:1991;330-338.
8. de Vries H.E., Blom-Roosemalen M.C.M., de Boer A.G., van Berkel T.J.C., Breimer D.D., Kuiper J. Effect of endotoxin on permeability of bovine cerebral endothelial cell layers in vitro. J. Pharmacol. Exp. Ther. 277:1996;1418-1423.
9. Ebisui O., Fukata J., Murakami N., Kobayashi H., Segawa H., Muro S., Hanaoka I., Naito Y., Masui Y., Ohmoto Y., Imura H., Nakao K. Effect of IL-1 receptor antagonist and antiserum to TNF-α on LPS-induced plasma ACTH and corticosterone rise in rats. Am. J. Physiol. 266:1994;E986-E992.
10. Eckman P.L., King W.M., Brunson J.G. Effects produced by a single injection of gram-negative endotoxin on the permeability of the cerebral vessels. Am. J. Pathol. 34:1958;631-639.
11. Gutierrez E.G., Banks W.A., Kastin A.J. Murine tumor necrosis factor alpha is transported from blood to brain in the mouse. J. Neuroimmunol. 47:1993;169-176.
12. Hasegawa T., Nadai M., Wang L., Haghgoo S., Nabeshima T., Kato N. Influence of endotoxin and lipid A on the renal handling and accumulation of gentamicin in rats. Biol. Pharm. Bull. 17:1994;1651-1655.
13. Kang Y.S., Bickel U., Pardridge W.M. Pharmacokinetics and saturable blood-brain barrier transport of biotin bound to a conjugate of avidin and a monoclonal antibody to the transferrin receptor. Drug Metab. Dispos. 22:1994;99-105.
14. Klir J.J., Roth J., Szelenyi Z., Mc Clellan J.L., Kluger M.J. Role of hypothalamic interleukin-6 and tumor necrosis factor-α in LPS-fever in rat. Am. J. Physiol. 165:1993;R512-517.
15. Krueger J.M., Majde J.A. Microbial products and cytokines in sleep and fever regulation. Crit. Rev. Immunol. 14:1994;355-379.
16. Lustig S., Danenberg H.D., Kafri Y., Kobiler D., Ben-Nathan D. Viral neuroinvasion and encephalitis induced by lipopolysaccharide and its mediators. J. Exp. Med. 176:1992;707-712.
17. Ohno K., Pettigrew K.D., Rapoport S.I. Lower limits of cerebrovascular permeability to nonelectrolytes in the conscious rat. Am. J. Physiol. 235:1978;299-307.
18. Pardridge W.M., Triguero D., Buciak J., Yang J. Evaluation of cationized rat albumin as a potential blood-brain barrier drug transport vector. J. Pharmacol. Exp. Ther. 255:1990;893-899.
19. Pardridge W.M., Kang Y.S., Buciak J.L. Transport of human recombinant brain-derived neurotrophic factor (BDNF) through the rat blood-brain barrier in vivo using vector-mediated peptide drug delivery. Pharm. Res. 11:1994;738-746.
20. Pitossi F., del Rey A., Kabiersch A., Besedovsky H.O. Induction of cytokine transcripts in the central nervous system and pituitary following peripheral administration of endotoxin to mice. J. Neurosci. Res. 48:1997;1-12.
21. Quagliarello V.J., Wispelwey B., Long W.J., Scheld W.M. Recombinant human interleukin-1 induces meningitis and blood-brain barrier injury in the rat. Characterization and comparison with tumor necrosis factor. J. Clin. Invest. 87:1991;1360-1366.
22. Rogausch H., del Rey A., Kabiersch A., Reschke W., Örtel J., Besedovsky H. Endotoxin impedes vasoconstriction in the spleen: role of endogenous interleukin-1 and sympathetic innervation. Am. J. Physiol. 272:1997;. (in press).
23. Samii A., Bickel U., Stroth U., Pardridge W.M. Blood-brain barrier transport of neuropeptides: analysis with a metabolically stable dermorphin analogue. Am. J. Physiol. 267:1994;E124-E131.
24. Smith Q.R., Rapoport S.I. Cerebrovascular permeability coefficients to sodium, potassium and chloride. J. Neurochem. 46:1986;1732-1742.
25. Takasato Y., Rapoport S.I., Smith Q.R. An in situ brain perfusion technique to study cerebrovascular transport in the rat. Am. J. Physiol. 247:1984;H484-H493.
26. Tunkel A.R., Rosser S.W., Hansen E.J., Scheld W.M. Blood-brain barrier alterations in bacterial meningitis: development of an in vitro model and observations on the effects of lipopolysaccharide. In Vitro Cell Dev. Biol. A. 27:1991;113-120.
27. Wispelwey B., Lesse A.J., Hansen E.J., Scheld W.M. Haemophilus influenzae lipopolysaccharide-induced blood brain barrier permeabilitiy during experimental meningitis in the rat. J. Clin. Invest. 82:1988;1339-1346.
28. Zhuang X., Silverman A.J., Silver R. Brain mast cell degranulation regulates blood-brain barrier. J. Neurobiol. 31:1996;393-403.